403 studies found for:    received in the last 14 days
Show Display Options
Rank Status Study
21 Not yet recruiting Does Transcutaneous Vagal Nerve Stimulation Improves Fear Extinction in Humans
Condition: Healthy Adults
Interventions: Device: t-VNS;   Device: sham stimulation
22 Not yet recruiting Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge
Conditions: Eosinophilic Esophagitis;   EoE
Intervention:
23 Not yet recruiting Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
Condition: Acromegaly
Interventions: Other: 1H/31P Magnetic Resonance Spectroscopy;   Other: oral glucose tolerance testing;   Other: Thyroid sonography
24 Not yet recruiting Phase II Trial of Rituximab In Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Rituximab;   Drug: Placebo
25 Withheld [Trial of device that is not approved or cleared by the U.S. FDA]
Condition:
Intervention:
26 Recruiting Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
Condition: Acute Pancreatitis
Intervention: Drug: Rectal indomethacin 100mg one time before or after ERCP
27 Not yet recruiting An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects
Condition: Healthy Subjects
Intervention: Drug: E2007
28 Recruiting REVITIVE for the Treatment of Patients With Venous Insufficiency
Conditions: Venous Insufficiency;   Oedema;   Varicose Veins
Intervention: Device: REVITIVE IX
29 Not yet recruiting Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma
Condition: Primary Central Nervous System Lymphoma
Intervention: Drug: Rituximab plus Temozolomide
30 Completed Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary Care
Conditions: Depression;   Dysthymia;   Ambulatory Health Services
Interventions: Other: Rational-Emotive-Behavioral Therapy;   Other: Control Group usual care
31 Completed Residual Gastric Volume in Morbidly Obesa Diabetics. A Comparison of 3 Hour Versus Hour Fasting.
Conditions: Obesity;   Diabetes;   Fasting
Intervention: Other: Endoscopic examinations
32 Active, not recruiting Study for the RevLite Laser System for Facial Solar Lentigines
Condition: Facial Solar Lentigines
Intervention: Device: Revlite Laser System
33 Not yet recruiting Treatment of Tracheostomy Granulomas
Conditions: Granuloma;   Tracheostomy
Interventions: Drug: Betadine;   Drug: Silver Nitrate;   Drug: Hydrocortisone Butyrate Cream, 0.1%
34 Not yet recruiting The Relationship Between the Sacroiliac Joint and Lumbopelvic Configurations With SIJ Nerve Entrapments and Chronic Low Back Pain.
Condition: Chronic Low Back Pain
Intervention:
35 Not yet recruiting An Observational Pilot Study of the Effects of Traumatic Haemorrhagic Shock and Resuscitation on the Microcirculation
Condition: Traumatic Haemorrhagic Shock
Intervention: Device: Side Stream Dark Field Microscopy
36 Not yet recruiting A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients
Condition: Post-ERCP Acute Pancreatitis
Interventions: Drug: Rectal Indomethacin;   Drug: Epinephrine
37 Not yet recruiting Low-Dose Total Lymphoid Irradiation in Treating Patients With Steroid-Resistant or Dependent Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant
Condition: Graft Versus Host Disease
Interventions: Radiation: total nodal irradiation;   Other: laboratory biomarker analysis;   Other: questionnaire administration
38 Completed Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
Conditions: Coagulation Dysfunction in Septic Shock;   Hemodynamic Improvement Induced by Hydrocortisone
Intervention: Drug: Hydrocortisone
39 Recruiting Indomethacin Decreases Post-ERCP Pancreatitis
Condition: Post ERCP Acute Pancreatitis
Interventions: Drug: Indomethacin;   Drug: 2.6-g suppository of glycerin
40 Recruiting Absolute Bioavailability of BMS-791325
Condition: Hepatitis C Virus Infection
Interventions: Drug: BMS-791325;   Drug: [13C]-BMS-791325

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years